Aging-dependent change in Th17 and cytokine response in multiple sclerosis
Abstract Background Multiple sclerosis (MS) is a chronic autoimmune disease damaging the central nervous system. Diminished inflammatory disease activity (DA) as people with MS (pwMS) age motivated randomized clinical trials assessing disease-modifying therapy (DMT) discontinuation in older pwMS giv...
Saved in:
| Main Authors: | Wen Zhu, Shankar Revu, Chenyi Chen, Megan Dahl, Archana Ramkumar, Conor Kelly, Mandy J. McGeachy, Zongqi Xia |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-06-01
|
| Series: | Journal of Neuroinflammation |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12974-025-03474-8 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Reconstitution of CXCR3+ CCR6+ Th17.1‐Like T Cells in Response to Ofatumumab Therapy in Patients With Multiple Sclerosis
by: Shu Yang, et al.
Published: (2025-05-01) -
Interaction between Th17 and central nervous system in multiple sclerosis
by: Shixin Lai, et al.
Published: (2025-02-01) -
Levels of circulating cytokines in children with multiple sclerosis with different effectiveness of interferon therapy
by: T. V. Radygina, et al.
Published: (2024-01-01) -
Role of CD20<sup>+</sup>T lymphocytes in the pathogenesis of multiple sclerosis
by: N. S. Glebezdina
Published: (2024-07-01) -
Salivary Levels of Interleukin-17 in Iranian Patients With Systemic Sclerosis
by: Ali Tadayon, et al.
Published: (2024-12-01)